Chiara Laezza

Institute of Endocrinology and Experimental Oncology

H指数:45

被引数:7,475

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma

更正：法尼基二磷酸合酶（FDPS）在胶质母细胞瘤中的表达和活性失调

Scientific Reports

IF3.9

2025-10-090

Antitumoral Activity of the Universal Methyl Donor S-Adenosylmethionine in Glioblastoma Cells

MOLECULES

IF4.6

2024-04-102

OAAI

Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris

大麻二酚对寻常型银屑病患者的pbmc具有多靶点免疫调节作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-03-272

OAAI

Advances in adiponcosis: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay

脂肪病的进展: 脂肪和肿瘤组织相互作用的内部机制的见解

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2022-12-076

N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells

N6-isopentenyladenosine通过程序性坏死诱导人胶质母细胞瘤细胞死亡

CELL DEATH DISCOVERY

IF7

2022-04-0715

OAAI

Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer Patients

结直肠癌患者 α B-晶体蛋白表达与肿瘤分化程度的关系

DIAGNOSTICS

IF3.3

2021-05-187

OAAI

Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets

新型冠状病毒肺炎的脂质稳态和甲羟戊酸途径: 基本概念和潜在治疗靶点

PROGRESS IN LIPID RESEARCH

IF14.9

2021-04-0124

OAAI

PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress

Ppar α 选择性拮抗剂GW6471抑制乳腺癌干细胞的细胞生长，诱导能量失衡和代谢应激

BIOMEDICINES

IF3.9

2021-01-2826

OAAI

Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer

胆固醇稳态调节人类卵巢癌的铂敏感性

CELLS

IF5.2

2020-03-3045

OAAI

N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression

FRONTIERS IN ONCOLOGY

IF3.3

2020-01-1413

OAAI

Novel role for cannabidiol in circadian clock function

ADDICTION BIOLOGY

IF2.6

2019-05-271

PREAI

Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma

SCIENTIFIC REPORTS

IF3.9

2017-10-2646

OAAI

N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux

CELL DEATH AND DIFFERENTIATION

IF15.4

2017-10-1354

OAAI

Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-09-2124

OAAI

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer

SCIENTIFIC REPORTS

IF3.9

2017-09-1555

OAAI

Cannabidiol: State of the art and new challenges for therapeutic applications

PHARMACOLOGY & THERAPEUTICS

IF12.5

2017-07-01440

PREAI

The isoprenoid derivative N6-benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2017-06-1114

OAAI

Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15

BIOCHIMIE

IF3

2017-04-017

OAAI

Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2016-11-1631

OAAI

p53 regulates the mevalonate pathway in human glioblastoma multiforme

p53调节人多形性胶质母细胞瘤的甲羟戊酸途径

CELL DEATH & DISEASE

IF9.6

2015-10-1542

OAAI

Chiara Laezza

个人简介

教育背景

工作经历

荣誉奖项

研究方向